Uropathogenic Escherichia coli (UPEC) causes most community-acquired and nosocomial urinary tract infections (UTI). In a mouse model of UTI, UPEC invades superficial bladder cells and proliferates rapidly, forming biofilm-like structures called intracellular bacterial communities (IBCs). Using a gentamicin protection assay and fluorescence microscopy, we developed an in vitro model for studying UPEC proliferation within immortalized human urothelial cells. By pharmacologic manipulation of urothelial cells with the cholesterolsequestering drug filipin, numbers of intracellular UPEC CFU increased 8 h and 24 h postinfection relative to untreated cultures. Enhanced UPEC intracellular proliferation required that the urothelial cells, but not the bacteria, be filipin treated prior to infection. However, neither UPEC frequency of invasion nor early intracellular trafficking events to a Lamp1-positive compartment were modulated by filipin. Upon inspection by fluorescence microscopy, cultures with enhanced UPEC intracellular proliferation exhibited large, dense bacterial aggregates within cells that resembled IBCs but were contained with Lamp1-positive vacuoles. While an isogenic fimH mutant was capable of forming these IBC-like structures, the mutant formed significantly fewer than wild-type UPEC. Similar to IBCs, expression of E. coli iron acquisition systems was upregulated by intracellular UPEC. Expression of other putative virulence factors, including hlyA, cnf1, fliC, kpsD, and the biofilm adhesin yfaL also increased, while expression of fimA decreased and that of flu did not change. These results indicate that UPEC differentially regulates virulence factors in the intracellular environment. Thus, immortalized urothelial cultures that recapitulate IBC formation in vitro represent a novel system for the molecular and biochemical characterization of the UPEC intracellular life cycle.
Urinary tract infections (UTI) are the second most common infectious disease, in which uropathogenic Escherichia coli (UPEC) causes approximately 80% of community-acquired infections and 40% of nosocomial infections (51, 62, 63) . UTI result in seven million clinic visits per year and cost $3.5 billion in treatment, representing a significant burden on the health care system (37) . Half of all women will suffer a UTI during their lifetime, with a 25% recurrence rate within 6 months (10, 15) . In 50% of these recurrent infections, the same UPEC strain causes both the primary and relapsing UTI (16, 25) .
Several host-pathogen interactions between urothelial cells and UPEC have been characterized, including UPEC induction of apoptosis, suppression of cytokine secretion, and invasion of urothelial cells (3, 4, 9, 11, 30, 31, 38, 40, 61) . UPEC invasion can be mediated by the Dr adhesin, which binds type IV collagen and decay-accelerating factor, or by type 1 pili, which binds mannose residues by the FimH adhesin. Invasion by either mechanism can result in a persistent infection (18, 19, 41, 43, 44, 56, 57) . When type 1 pilus-expressing UPEC is internalized, UPEC proliferates and differentiates into intracellular bacterial communities (IBCs), compact aggregates of intracellular bacteria with biofilm-like properties that have been characterized in a murine UTI model (1, 26, 71) . IBCs are primarily identified visually by their morphology and location. IBCs are globular in shape, are tightly packed with coccoid bacteria, and typically occupy most of the host cell cytoplasm, causing urothelial cell distortion. Formation occurs 6 to 24 h postinfection, and IBCs express antigen 43 and type 1 pili and secrete a polysaccharide matrix (1, 26) . Bacterial genes leuX, fimH, and surA are required for IBC formation, and several iron acquisition systems are upregulated in IBCs (22, 26, 48, 71) . Similar to the murine model, IBC-like structures have been identified during human UTIs. Exfoliated cells exhibiting features resembling IBCs were found in patient urine samples, and UPEC isolates originating from asymptomic bacteriura, pyelonephritis, and cystitis patients formed IBCs in the murine UTI model (17, 52) .
Replicating the conditions required for IBC formation in vitro has proven to be difficult. One report described formation of IBC-like structures in a bladder carcinoma cell line after host cell permeabilization with a detergent (12) . The absence of in vitro models is potentially due to the lack of cell lines that sufficiently recapitulate urothelial characteristics. Here we establish an in vitro model of IBC formation by pharmacologic manipulation of immortalized human urothelial cells. Our immortalized cell lines retain numerous characteristics of urothelial cells, including differentiation, inflammatory response, and apoptosis (3, 4, 30, 31, 39, 49, 64, 65) . The IBC-like structures reported here are visually and morphologically similar to IBCs formed in the murine UTI model, occur with comparable kinetics, and similarly upregulate iron acquisition systems. Additionally, IBC formation is attenuated in a UPEC mutant lacking fimH. Thus, we have developed a model for studying UPEC IBC formation in vitro. 594 and chicken anti-goat-Alexa Fluor 488, labeling caveolin-1 red and E. coli green. PD07i cell nuclei were counterstained with DAPI.
(iv) Intracellular proliferation. To qualitatively examine intracellular proliferation, PD07i cells were infected with NU14 expressing green fluorescent protein (NU14-GFP; MOI of 100). After 2 h, gentamicin (100 g/ml) was applied, and cells were incubated at 37°C and 5% CO 2 for 22 h. Extracellular bacteria were stained, samples were fixed, and urothelial nuclei were stained as described above. To quantitatively examine intracellular proliferation, cells were infected with NU14 (MOI of 10) Ϯ filipin as described above. After the 22-h incubation with gentamicin, extra-and intracellular bacteria were differentiated either by antibody incubation, as described above, or with the intercalating dye SYTO 9 (Invitrogen). The staining method did not affect the experimental outcome (data not shown). To differentiate intracellular and extracellular bacteria with SYTO 9, cultures were incubated with goat anti-E. coli antibody prior to fixation to label extracellular bacteria only. Samples were then permeabilized with 0.1% saponin for 5 min at 25°C to reduce background staining of the urothelial cell by SYTO 9. (Even with this permabilization step, SYTO 9 still stained urothelial nucleoli, which were easily identifiable and differentiated from E. coli.) Samples were then incubated with SYTO 9 (1.5:1,000) for 15 min to stain all bacteria green and fixed with PLP solution for 30 min, followed by incubations with rabbit anti-goatAlexa Fluor 594 to label extracellular bacteria red and DAPI to stain urothelial nuclei blue. One hundred cells containing intracellular bacteria were scored for having 1 to 5, 6 to 20, or Ͼ20 intracellular bacteria or containing IBC-like structures.
All microscopic samples were washed four times with PBS-5% sucrose between each step, all antibodies were diluted 1:500, and all steps were incubated rocking for 30 min at room temperature unless indicated otherwise. Samples were mounted with Prolong Antifade (Invitrogen). Images were acquired on a Leica DMIRE microscope using Volocity acquisition and deconvolution software (Improvision). Z stacks were acquired in 0.1-m intervals at ϫ63 or ϫ100, and stacks were deconvolved (25 iterations, 95% confidence). Images represent all slices of the Z stack compressed into one two-dimensional image unless otherwise indicated. Figure 1B was acquired on a Nikon Eclipse E800.
(v) Electron microscopy. PD07i cells in 35-mm-diameter dishes were infected with NU14 for 2 h (MOI of 100) as described above and fixed in 2.5% glutaraldehyde-0.1 M cacodylate buffer overnight. Samples were rinsed in 0.1 M cacodylate buffer, incubated in 2% osmium for 2 h, and then rinsed with distilled water. Samples were stained with uranyl acetate, rinsed with distilled water, and dehydrated with ethanol. Samples were embedded in a 1:1 mixture of ethyl alcohol-resin (mixture of araldite and Epon 812) and then incubated in a 60°C oven overnight. Specimens were sectioned with a diamond knife and mounted onto grids for imaging on a JEOL 1220 electron microscope.
Real-time PCR with RNA harvested from intracellular NU14. PD07i cells were incubated with NU14 (MOI of 100) for 2 h, followed by addition of gentamicin (100 g/ml) to the culture medium for 22 h. To isolate intracellular bacteria, infected cultures were washed twice with PBS, incubated with RLT buffer (Qiagen) for 2 min, and vortexed for 1 min, followed by centrifugation for 1 min at 16,000 ϫ g. This method has been shown to yield high-quality RNA for highly sensitive assays such as microarray analysis (8) . Bacterial pellets were washed with PBS, and bacterial RNA was purified using the GenElute bacterial RNA harvest kit (Sigma). cDNA was synthesized with the iScript cDNA synthesis kit (Bio-Rad), and real-time PCR was performed with IQ SYBR green SuperMix (Bio-Rad) according to the manufacturer's instructions. Each condition was analyzed in duplicate. Real-time PCR was performed on an MJ Research PTC-200 Peltier thermal cycler, and data were recorded by the Opticon Monitor 3 software. Change in mRNA levels was determined using the 2 Ϫ⌬⌬CT method, with gyrB as an internal control (45) . The primers used are listed in Table 2 . Primers did not amplify any product from uninfected PD07i cultures processed as described above.
Statistical analyses. A two-tailed unpaired t test, one-way analysis of variance, and two-way analysis of variance statistical analyses were performed using Prism 4.0a software (Graphpad Software). Data were considered significantly different at P Ͻ 0.05.
RESULTS
Intracellular proliferation by UPEC. We previously found that the immortalized human bladder cell line PD07i recapitulates many aspects of UPEC-urothelial cell interactions characterized in vivo, including FimH-dependent apoptosis, inflammatory responses, and UPEC binding and invasion (3, 4, 30, 31, 64, 65) . To further explore UPEC-urothelial cell interactions, we tested the capacity of UPEC to proliferate within PD07i cells by gentamicin protection assay (GPA). PD07i cells were infected with the prototypical UPEC strain NU14 for 2 h, and then samples were incubated with gentamicin for 0.5 h to 22 h to kill extracellular bacteria, and detergent lysates were plated on agar to enumerate intracellular CFU. After 24 h, numbers of intracellular bacteria were significantly increased relative to numbers of intracellular bacteria after 2 h of infection (Fig. 1A) (P Ͻ 0.01). To determine if the increase in intracellular bacteria was due to intracellular proliferation, PD07i cells were incubated with NU14-GFP and then examined by immunofluorescence at 2 h and 24 h postinfection. To discriminate intracellular bacteria from extracellular bacteria, a dual staining was performed, whereby extracellular bacteria were first antibody stained prior to sample fixation and permeabilization so that the eukaryotic membrane protected intracellular bacteria from labeling. After 2 h of infection, intracellular NU14-GFP was rod shaped and distant from the host cell nucleus (Fig. 1B) . PD07i cells contained 1.6 Ϯ 0.5 invasive bacteria per cell, indicating that only 1 or 2 bacteria invaded each urothelial cell (n ϭ 5). After 24 h, clusters of intracellular bacteria were identified within PD07i cells. Intracellular NU14-GFP appeared rod shaped, and clusters localized to the perinuclear space or were spread throughout the host cell cytoplasm (Fig. 1C and D) . Examination of infected cells by electron microscopy showed similar distributions of intracellular bacteria after 24 h and suggested that the intracellular bacteria were membrane associated ( Fig. 1E and F) . To quantify NU14 intracellular proliferation, we counted the number of PD07i cells containing intracellular UPEC and classified these cells as containing 1 to 5, 6 to 20, or Ͼ20 bacteria/cell (Table 1) . While nearly 80% of infected cells contained 1 to 5 bacteria after 24 h, 17.9% contained 6 to 20 bacteria, and 3.6% contained Ͼ20 bacteria. Together, these data suggest that NU14 proliferates within PD07i cells.
Filipin enhances UPEC intracellular proliferation. Cholesterol and lipid rafts have previously been implicated in UPEC invasion (9) . We examined the role of lipid rafts in our PD07i model by using cholesterol-modifying drugs, including the cholesterol-sequestering agent filipin. When PD07i cultures were pretreated with filipin, the number of intracellular bacteria harvested after 24 h increased significantly relative to vehicletreated PD07i cultures ( Fig. 2A) . Intracellular bacteria increased threefold over 24 h in vehicle-treated cells, while intracellular bacteria increased almost eightfold in filipin-pretreated PD07i cells, indicating that filipin enhanced NU14 intracellular proliferation ( Fig. 2B ). This effect was specific to filipin, for no difference in proliferation was seen when PD07i cultures were treated with other cholesterol-modifying drugs, including M␤CD and nystatin (data not shown). This fortuitous finding led us to speculate whether the proliferation of intracellular UPEC had been altered. To determine if filipin affected the morphology or distribution of proliferating intracellular bacteria, PD07i cultures were pretreated with filipin, infected with NU14-GFP, and then examined by fluorescence microscopy. At 24 h, intracellular NU14-GFP within filipin-pretreated PD07i cells appeared morphologically distinct from intracellular bacteria within untreated cells (compare Fig. 1C and D to 3A and B). Bacteria within vehicle-treated cells, which were indistinguishable from bacteria within untreated cells, appeared as loosely associated clusters, while bacteria within filipin-treated cells were packed together into globular, dense aggregates sufficiently sizeable to occupy large areas of the cell volume. These aggregates were often so large as to distort the nucleus itself. While filipin pretreatment did not affect the overall number of infected PD07i cells, filipin induced formation of these globular, dense aggregates in 5.2% of infected cells and significantly decreased the percentage of infected cells containing 6 to 20 bacteria (Table 1) . Additionally, urothelial cells harboring these dense aggregates contained more bacteria per cell than vehicletreated PD07i cells and were morphologically similar to the cytosolic IBCs reported in the murine UTI model (1, 26, 71) . To determine if in vitro IBC-like structures are also cytosolic, samples were examined by electron microscopy. Imaging by electron microscopy confirmed the observed change in NU14 intracellular distribution and also suggested that these dense, globular aggregates were membrane bound (Fig. 3C) . When samples were stained with the endosomal/lysosomal marker Lamp1, the IBC-like structures were surrounded by Lamp1 stain, suggesting containment within a Lamp1 vacuole (Fig.  3D) . Thus, while in vitro IBC-like structures are morphologically similar to in vivo IBCs, they localize to a different compartment within urothelial cells.
Having identified IBC-inducing conditions in vitro, we sought to investigate the kinetics of the system and identify the system component modified by filipin. To this end, formation of IBC-like structures was characterized by a time course, a filipin dose curve, and an NU14 MOI curve. When the formation of IBC-like structures was characterized in a 24-h time course, two incidences of enhanced intracellular proliferation were observed: the first 6 to 8 h postinfection and the second 22 to 24 h postinfection (Fig. 2C) . These data suggest that IBC-like structures appear with similar kinetics to in vivo IBCs (26) . Filipin-enhanced intracellular proliferation increased as the filipin concentration increased and remained consistent over a range of bacterial MOIs ( Fig. 2D and E) . These data indicate that filipin induces proliferation independent of infecting dose of bacteria with similar kinetics to the in vivo UTI model. Although pretreatment of PD07i cultures enhanced NU14 intracellular proliferation, it was unclear whether filipin was acting on urothelial cells or on UPEC. Thus, to clarify where filipin was having an effect, either PD07i cultures or NU14 culture was treated with filipin prior to infection and NU14 intracellular proliferation was measured by GPA (Fig.  2F) . As previously shown, when PD07i cultures were pretreated with filipin, intracellular bacterial proliferation was significantly higher than intracellular proliferation in vehicletreated cultures (P Ͻ 0.05). Conversely, when NU14 was treated with filipin and then used to infect PD07i cultures, proliferation did not change. When both PD07i cells and bacteria were pretreated with filipin, proliferation was significantly increased over that of the control (P Ͻ 0.01). These data indicate that filipin acts on urothelial cultures, not the bacteria, to induce formation of IBC-like structures. We next addressed whether the timing of filipin treatment influenced the formation of IBC-like structures. To this end, PD07i cells were treated with filipin either for 1 h prior to or for 1 h after NU14 infection. As previously seen, pretreatment of PD07i cells resulted in significantly higher NU14 intracellular proliferation relative to the vehicle-treated cultures (Fig.  2G) . Treatment of cells postinfection slightly enhanced proliferation; however, this increase was not significantly different from vehicle-treated cultures. We also investigated whether IBC-like structures could be induced in another bladder cell line. The 5637 cell line is a bladder carcinoma cell line commonly used to study UPEC pathogenesis in vitro, yet filipin did not increase NU14 proliferation within 5637 cells (Fig. 2H) . These data suggest that filipin acts on urothelial cells prior to bacterial infection to induce cellular changes that support enhanced UPEC proliferation and that not all urothelial cells are competent to support enhanced intracellular growth.
Filipin does not affect NU14 invasion of PD07i cells. Because filipin pretreatment was required, it was possible that filipin altered bacterial invasion, thereby leading to an alternative intracellular fate and IBC formation. To explore this possibility, PD07i cultures were pretreated with filipin, and NU14 invasion was measured by GPA and normalized to bacterial adherence. Pretreatment of PD07i cells with filipin had no effect on NU14 adherence or invasion efficiency (Fig. 4A ) (data not shown). Filipin is a cholesterol-binding agent often used to disrupt lipid rafts, and the observation that filipin does not affect NU14 invasion contradicts previous reports suggesting that lipid rafts and caveolae are required for FimH-expressing E. coli to invade bladder cells (9) . To investigate whether UPEC uses caveolae to invade PD07i cells, lipid rafts were disrupted with the cholesterol-extracting drug M␤CD prior to NU14 infection. M␤CD treatment resulted in decreased invasion efficiency compared to treatment with the vehicle control (Fig. 4B) . To corroborate the GPA results, invasion was quantified by microscopy ( Fig. 4C) . M␤CD pretreatment resulted in decreased NU14 invasion (P Ͻ 0.05), while filipin pretreatment did not affect invasion, confirming that cholesterol and lipid rafts were required for invasion. As further verification that caveolae mediate UPEC invasion, PD07i cells were stained for E. coli and for caveolae. In both vehicle-treated and filipin-treated cultures, NU14 localized to caveolae ( Fig. 4E and F) . Additionally, knocking down caveolin-1 by RNA interference resulted in significantly decreased NU14 invasion, suggesting that caveolae mediate NU14 invasion in PD07i cultures (data not shown). We also examined NU14 early intracellular trafficking events and found that after 2 h, 43% of intracellular NU14 colocalized with host endosomal/lysosomal marker Lamp1 (Fig. 4G) . We quantified Lamp1 colocalization after filipin pretreatment and found that there was no significant difference relative to vehicle-treated samples (Fig. 4D) . Together, these data suggest that filipin does not disrupt invasion or Lamp1 association to induce in vitro IBCs.
Role of FimH in IBC formation in vitro. Previous reports suggest that FimH is required for IBC formation (71) . To determine if in vitro IBC-like structures require FimH, PD07i cultures were infected with the fimH mutant NU14-1, and adherence, invasion, and intracellular proliferation were measured by GPA. NU14-1 was significantly deficient for adherence compared to NU14, and NU14-1 adherence was not influenced by filipin (Fig. 5A) . We next quantified invasion by NU14-1. While previous studies report that UPEC invasion requires FimH, we found that invasive NU14-1 was detectable by both GPA and by immunofluorescence at an MOI of 100 and that NU14-1 invasion increased significantly with filipin pretreatment. (P Ͻ 0.05) (Fig. 5B and D) . To determine if NU14-1 was subject to filipin-enhanced proliferation, intracellular bacteria were quantified 24 h postinfection by GPA. We found that filipin significantly increased the number of intracellular NU14-1 CFU and induced IBC-like structures ( Fig. 5C and E). The number of bacteria/cell was enumerated to quantify intracellular proliferation, and in vehicle-treated cultures, all cells containing intracellular NU14-1 had fewer than five bacteria per cell, indicating that NU14-1 cannot proliferate within PD07i cells (Table 1) . Under IBC-inducing conditions, IBC-like structures appeared in 2% of infected cells; however, NU14-1 formed significantly fewer in vitro IBCs than NU14 (P Ͻ 0.01). These data suggest that fimH is not absolutely necessary for invasion but is required for intracellular proliferation, a requirement that is partially relieved under IBCinducing conditions.
FIG. 4. Filipin does not affect NU14 invasion of PD07i cells. (A)
PD07i cells were pretreated with a vehicle control (MeOH) or filipin (1 g/ml) and then infected with NU14 (MOI of 10) for 2 h. Invasion was measured by GPA and expressed as a percentage of adherent bacteria. Filipin had no effect on invasion (n ϭ 10), but pretreatment with M␤CD (7.5 mg/ml) (B) significantly inhibited NU14 invasion ( * , P ϭ 0.007; n ϭ 4). (C) PD07i cells were infected with NU14 as described above after pretreatment with the vehicle control (white bars) or the indicated drug (black bars), and invasion was measured by fluorescence microscopy of samples stained for extracellular and total bacteria as described in Materials and Methods. In vitro IBCs upregulate expression of iron acquisition systems. Because IBCs are mainly identified by morphology, there are no definitive markers for confirming that the globular, dense aggregates observed in our in vitro model are IBCs. However, expression of several genes involved in iron acquisition was measured and the genes were found to be upregulated in mouse IBCs (48) . To further characterize in vitro IBCs, we measured gene expression of several iron acquisition systems under IBC-inducing and noninducing conditions. Thus, PD07i cultures were pretreated with vehicle control or filipin and infected with NU14 for 24 h. Intracellular bacteria were isolated, bacterial RNA was purified, and real-time reverse transcription-PCR (RT-PCR) was performed on 15 potential virulence factors (Table 2) (8) . Gene expression of intracellular bacteria was normalized to that of bacteria grown in PD07i culture medium under static conditions. We examined the expression of genes involved in several iron acquisition systems that are upregulated in IBCs: chuA, fepA, iroN, sitA, entF, tonB, and ybtS (Fig. 6A to G and Table  2 ) (48). These genes have been reported by multiple groups to be important for UPEC pathogenesis in vivo, so expression in vitro would be indicative of a model that closely mimics in vivo events (6, 21) . We found that under IBC-inducing conditions, expression of fepA, iroN, entF, tonB, and ybtS was significantly elevated compared to static growth conditions, while expression of sitA remained unchanged (Fig. 6A to G, compare condition M to condition F). chuA expression was elevated, but expression was not significantly higher under IBC-inducing conditions than in culture medium. With the exception of sitA, our in vitro IBCs show the same trend in expression of iron acquisition systems as IBCs within mouse bladders. Notably, the same changes in gene expression were observed under noninducing conditions, suggesting that the urothelial intracellular environment is sufficient to alter UPEC gene expression (see Discussion). We also measured the expression of several other virulence factors proposed to play a role in UPEC pathogenesis, including fliC, fimA, flu, yfaL, kpsD, hlyA, and cnf1 (Table 2) . hlyA, which is upregulated in mouse IBCs, was also significantly upregulated under IBC-inducing conditions (Fig. 6M) (20, 58, 59, 67, 70) . fliC is downregulated in mouse urine but upregulated during growth in human urine and was upregulated under intracellular conditions in our model (Fig. 6H) (60) . Expression of other putative virulence factors, including yfaL, cnf1, and kpsD, was also upregulated by the intracellular environment, yet kpsD expression increased significantly only under noninducing conditions. fimA, coding for the major subunit of type 1 pili, was downregulated relative to expression in culture medium (Fig. 6I , K, L, and N) (1, 60, 71) . However, overall expression remained relatively high as fimA expression in culture medium was 10-fold higher than that of the internal control, gyrB (data not shown). flu expression remained constant between culture medium and intracellular conditions, corroborating observations that antibodies to antigen 43 react with both extracellular and intracellular UPEC (Fig. 6J) (1, 60, 68 ; data not shown). Thus, other virulence factor genes exhibited changes in expression associated with the PD07i intracellular environment.
DISCUSSION
UPEC undergoes extensive intracellular proliferation within mouse bladder cells to form cytosolic, biofilm-like IBCs by 6 to 24 h postinfection. In the murine UTI model, IBCs embed in a secreted polysaccharide, express antigen 43 and type 1 pili, require bacterial genes fimH, leuX, and surA, and upregulate iron acquisition systems (1, 22, 26-28, 41, 42, 48, 71) . Using light microscopy, immunofluorescence, and electron microscopy, similar IBCs were identified in human urine samples by morphology and intracellular location (52) . Using a gentamicin protection assay, immunofluorescence, and electron microscopy, we identified in vitro conditions whereby large dense aggregates with IBC morphology form within immortalized human urothelial cells (Table 3 ). Similar to in vivo IBCs, in vitro IBCs form 6 to 24 h postinfection, upregulate iron acquisition systems, and express antigen 43. However, in contrast to in vivo IBCs that appear cytosolic (1), in vitro IBCs are contained in a Lamp1 compartment. Nonetheless, our in vitro IBC model shares many characteristics with in vivo IBCs, suggesting that this system will be useful for identifying host and bacterial factors required for IBC formation.
We also investigated the requirement for fimH in UPEC invasion and IBC formation in vitro. Previous reports state that FimH is required for UPEC invasion, yet very low levels of invasion, proliferation, and IBC formation by a fimH mutant have been documented (38, 71) . We found the fimH mutant FIG. 6 . In vitro IBCs upregulate expression of putative UPEC virulence factors. PD07i cells were pretreated with the vehicle control (V) or filipin (F) and then infected with NU14 (MOI of 100) for 2 h followed by addition of gentamicin to the culture medium for 22 h. Bacteria were isolated from PD07i cells, and bacterial RNA was harvested as detailed in Materials and Methods. RNA was also prepared from NU14 grown in culture medium (M) under static conditions for 24 h. Each condition was performed in duplicate, and each RNA sample was assayed in duplicate using the 2 Ϫ⌬⌬CT method. Values were normalized to gyrB mRNA levels and are expressed as change (fold) from gene expression in culture medium. Graphs represent the means of three experiments Ϯ standard errors of the mean. * , P Ͻ 0.05. (A to G) Genes involved in iron acquisition.
(H to N) Putative UPEC virulence factors. See Table 2 for gene details. (Table 1 ). These data suggest that intact type 1 pili are not required for IBC formation but instead influence the frequency with which IBCs form. We also found that under IBC-inducing conditions, NU14-1 invasion increased significantly (twofold) (Fig. 5B) . These data suggest that IBC-inducing conditions enhance a fimH-independent invasion mechanism that targets bacteria to an alternative intracellular niche that is permissive for IBC formation. Identification of bacterial and host receptors responsible for enhanced NU14-1 invasion will help identify conditions under which IBCs are established and bacterial mechanisms of IBC formation.
We examined gene expression of virulence factors and compared expression profiles of intracellular bacteria to those of bacteria grown in culture medium ( Table 2 ). There was a general increase in expression between medium and intracellular environments, but only kpsD expression was different between noninducing and IBC-inducing conditions (Fig. 6) . Registad et al. compared iron acquisition gene expression by IBCs, which are intracellular by definition, to gene expression in extracellular bacteria obtained from culture medium or intestine (48) . No comparison between IBCs and intracellular but non-IBC bacteria was possible, so while genes were upregulated in IBCs relative to extracellular environments, expression patterns were not necessarily IBC specific. Our studies were also limited in that only 5.2% of cells containing bacteria had IBC structures (Table 1) , so gene induction under IBC-inducing conditions may be masked by the presence of non-IBC intracellular bacteria. However, since the NU14 contained within in vitro IBCs outnumber intracellular NU14 underbasal conditions approximately threefold (Fig. 2B) , quantitative RT-PCR data likely reflect IBC gene expression. Based upon these considerations, our data suggest that upregulation of iron acquisition systems and other virulence factors are not specific to IBCs but are characteristic of intracellular UPEC, consistent with other intracellular pathogens (13, 46) .
In measuring gene expression of virulence factors, we found intracellular UPEC downregulated fimA; upregulated fliC, kpsD, yfaL, cnf1, and hlyA; and did not alter flu expression (Fig.  6 ). Decreased fimA expression may reflect a reduced need for lengthy type 1 pili within the limited intracellular space. Since type 1 pilus expression represses flagellar expression, decreased expression of the fim operon likely derepresses fliC, resulting in increased fliC expression by intracellular bacteria (33) . K1 capsule masks bacterial surface structures, which helps decrease detection by immune surveillance, decrease phagocytosis, and modulate trafficking of E. coli-containing vacuoles (29, 50, 53, 69) . Thus, increased kpsD expression could help direct UPEC intracellular trafficking and avoid lysosomal degradation. Alternatively, antigen 43 function is blocked by both K1 capsule and type 1 pili (23, 53) . The combination of decreased fim expression and the drop in kpsD expression under IBC-inducing conditions compared to basal conditions may permit antigen 43-mediated autoaggregation, thus facilitating biofilm and IBC formation. Cnf1 inactivates GTPases, which has multiple effects on the cell, including actin reorganization (5, 7, 14, 32, 35, 36, 54, 59) . A previous report suggests that UPEC intracellular proliferation is restricted by actin structure, so cnf1 upregulation may disrupt the actin network, facilitating UPEC intracellular growth (12) . Overall, virulence factor gene expression patterns of in vitro IBCs support and extend previous observations and suggest testable hypotheses for the UPEC intracellular life cycle.
IBC-inducing conditions required urothelial cell pretreatment with filipin, indicating that host cell modification prior to infection facilitates IBC formation. In vitro IBC formation within a Lamp1 vacuole suggests that filipin modifies subcellular compartments to permit IBC formation. These compartments likely have nearly identical conditions to umbrella cells that support IBC formation, and examination of host changes that have occurred in these compartments will help identify cellular environments permissive to IBC formation. Although filipin modifies cholesterol, cholesterol is not the sole factor mediating IBC formation, as other cholesterol-modifying drugs do not have this effect. Others have also reported that M␤CD and filipin have differential effects. In a model of B-cell signaling, M␤CD fully disrupted lipid rafts while filipin left them only partially disrupted (2) . Filipin could exert differential effects on specific domains within the urothelial cell plasma membrane, perhaps leaving some lipid rafts intact, such as caveolae that mediate invasion, while disrupting others. Other groups have observed that Toll-like receptor 4 (TLR4) knockout mice form more IBC than wild-type mice and that TLR4 knockdown urothelial cultures exhibited increased UPEC invasion (61) . TLR4 agonist promote receptor translocation to lipid rafts, and filipin can abrogate TLR4-mediated signaling (24, 66) . Thus, we speculate that filipin differentially disrupts urothelial lipid rafts, such as TLR4-containing rafts, but leaves caveolae intact, thereby leading to the enhanced fimH-independent invasion and subsequent IBC formation. Alternatively, filipin also decreases adenylate cyclase activity and cyclic AMP (cAMP) levels, and an adenylate cyclase-3-dependent pathway was recently described that mediates cAMP-dependent fluxing of E. coli out of urothelial cells (61) . Therefore, filipin-induced decreases in cAMP could promote fimH-independent invasion and retention, thus shifting the equilibrium toward IBC formation. Future experiments will resolve these competing models.
In summary, here we present a model of UPEC IBC formation in urothelial cultures. IBCs formed in vitro are morphologically comparable to in vivo IBCs and share many physical characteristics. This model will facilitate biochemical and genetic studies of host and pathogen requirements for IBC formation and UPEC pathogenesis. Finally, this system will accelerate the identification and testing of novel therapeutics for eradication of IBCs in the treatment and prevention of UTIs.
